ReviewAdvances in therapy2023

A Narrative Review of Real-World Data on the Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

Anna J Podolanczuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.